Glimepiride sulfonamide

CAS No. 119018-29-0

Glimepiride sulfonamide( —— )

Catalog No. M35785 CAS No. 119018-29-0

Glimepiride sulfonamide is an antiinflammatory agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 28 In Stock
200MG 40 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Glimepiride sulfonamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Glimepiride sulfonamide is an antiinflammatory agent.
  • Description
    Glimepiride sulfonamide is a intermediate, and can be used to synthesize Glimepiride (HY-B0104) (antidiabetic agent).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Immunology/Inflammation related
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119018-29-0
  • Formula Weight
    351.42
  • Molecular Formula
    C16H21N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(N)(=O)=O)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Parmar HS, et al. Study on gluco-regulatory potential of glimepiride sulfonamide using in silico, in vitro and in vivo approaches. Curr Pharm Des. 2014;20(32):5212-7.?
molnova catalog
related products
  • Licarin A b

    Licarin A ((+)-Licarin A), a neolignan, significantly and dose-dependently reduces TNF-α production (IC50=12.6 μM) in dinitrophenyl-human serum albumin (DNP-HSA)-stimulated RBL-2H3 cells. Anti-allergic effects. Licarin A reduces TNF-α and PGD2 production, and COX-2 expression.

  • Melanocyte Protein P...

    GP100 (209-217) is a 9-aa peptide derived from human gp100 beginning at position 20.

  • TM-25659

    TM-25659 is a modulator of transcriptional co-activator with PDZ-binding motif (TAZ), with anti-osteoporotic and anti-obesity activities.